Diabetes Drug Class Appears to Reduce Recurrent Gout Flares

Previously associated with a lower incidence of gout, sodium-glucose cotransporter-2 (SGLT2) inhibitors for the first time also appear to reduce gout flare recurrence and excess mortality.
Medscape Medical News

source https://www.medscape.com/viewarticle/996025?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost